
Adaptive Phage Therapeutics
Get Full AccessDescription
- Adaptive Phage Therapeutics, Inc. (APT) is a clinical-stage company founded to provide an effective therapeutic response to the global rise of multi-drug resistant (MDR) pathogenic bacteria. Two key components of APTs approach are 1) PhageBank, a large and dynamically growing collection of bacteriophages or phages (viruses that attack specific targeted bacteria) and 2) an innovative rapid system for matching phage to patient-specific bacterial infections. In 2016 APTs approach achieved its first in-human success with the rescue of a critically ill MDR infected patent.
-
Headquarters:22 Firstfield Road , Gaithersburg, Maryland, United States
More -
Phone Number: +1 240-912-9439
-
Website: https://www.aphage.com
-
Employees:28
-
Revenue:$10 - 50M
-
Legal Name:Adaptive Phage Therapeutics
-
Adaptive Phage Therapeutics's Social Media
-
Is this data correct?
-
| NAICS Code: 541713 |
Show More
Frequently Asked Questions regarding Adaptive Phage Therapeutics
-
Where are Adaptive Phage Therapeutics's Headquarters?
Adaptive Phage Therapeutics's Headquarters are in 22 Firstfield Road ,Gaithersburg,Maryland,United States
-
What is Adaptive Phage Therapeutics's phone number?
Adaptive Phage Therapeutics's phone number is +1 240-912-9439
-
What is Adaptive Phage Therapeutics's official website?
Adaptive Phage Therapeutics's official website is https://www.aphage.com
-
What is Adaptive Phage Therapeutics's Revenue?
Adaptive Phage Therapeutics's revenue is $10 - 50M
-
What is Adaptive Phage Therapeutics's NAICS code?
Adaptive Phage Therapeutics's NAICS code is 541713
-
How many employees are working in Adaptive Phage Therapeutics
Adaptive Phage Therapeutics has 28 employees
-
What is Adaptive Phage Therapeutics's Industry?
Adaptive Phage Therapeutics is in the industry of Biotechnology
-
Who is Adaptive Phage Therapeutics's CEO?
Adaptive Phage Therapeutics's CEO is Greg Merril